Patents by Inventor Xinbi Li

Xinbi Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINS BINDING NKG2D, CD16 AND BAFF-R
    Publication number: 20240360223
    Abstract: Multispecific binding proteins that bind NKG2D receptor, CD16, and B cell-activating factor receptor (BAFF-R) are described, as well as pharmaceutical compositions and therapeutic methods of the multispecific binding proteins useful for the treatment of cancer and autoimmune inflammatory diseases.
    Type: Application
    Filed: March 29, 2024
    Publication date: October 31, 2024
    Inventors: Aaron BELLI, Ann F. CHEUNG, Stacey V. DRABIC, Daniel FALLON, Benjamin FISCHER, Asya GRINBERG, Pyae P. HEIN, Alexander IVANOV, Zong Sean JUO, Mark LEWANDOWSKI, Xinbi LI, Matthew SCHNEIDER
  • PROTEINS BINDING NKG2D, CD16 AND BAFF-R
    Publication number: 20240270861
    Abstract: Multispecific binding proteins that bind NKG2D receptor, CD16, and B cell-activating factor receptor (BAFF-R) are described, as well as pharmaceutical compositions and therapeutic methods of the multispecific binding proteins useful for the treatment of cancer and autoimmune inflammatory diseases.
    Type: Application
    Filed: March 28, 2024
    Publication date: August 15, 2024
    Inventors: Aaron BELLI, Ann F. CHEUNG, Stacey V. DRABIC, Daniel FALLON, Benjamin FISCHER, Asya GRINBERG, Pyae P. HEIN, Alexander IVANOV, Zong Sean JUO, Mark LEWANDOWSKI, Xinbi LI, Matthew SCHNEIDER
  • ANTIBODIES TARGETING BAFF-R AND USE THEREOF
    Publication number: 20240228645
    Abstract: Disclosed are proteins with antibody heavy chain and light chain variable domains that can be paired to form an antigen-binding site targeting BAFF-R on a cell, pharmaceutical compositions comprising such proteins, and therapeutic methods using such proteins and pharmaceutical compositions, including for the treatment of cancer or autoimmune disease.
    Type: Application
    Filed: March 28, 2024
    Publication date: July 11, 2024
    Inventors: Benjamin FISCHER, Pyae P. HEIN, Alexander IVANOV, Xinbi LI, Matthew SCHNEIDER
  • ANTIBODIES TARGETING 5T4 AND USES THEREOF
    Publication number: 20230220106
    Abstract: Disclosed are proteins with antibody heavy chain and light chain variable domains that can be paired to form an antigen-binding site targeting 5T4 on a cell, pharmaceutical compositions comprising such proteins, and therapeutic methods using such proteins and pharmaceutical compositions, including for the treatment of cancer.
    Type: Application
    Filed: December 6, 2022
    Publication date: July 13, 2023
    Inventors: Pyae P. Hein, Zong Sean Juo, Xinbi Li, Christopher Ryan Morgan
  • PROTEINS BINDING NKG2D, CD16 AND 5T4
    Publication number: 20230203202
    Abstract: Multispecific binding proteins that bind NKG2D receptor, CD16, and 5T4 are described, as well as pharmaceutical compositions, formulations, and therapeutic methods of the multispecific binding proteins useful for the treatment of cancer.
    Type: Application
    Filed: December 6, 2022
    Publication date: June 29, 2023
    Inventors: Mitchell Bigelow, Mark DeRose, Jinyan Du, Robin Friedman, Pyae P. Hein, Stuart William Hicks, Zong Sean Juo, Xinbi Li, Christopher Ryan Morgan